Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies998
SiL Vascular
SiL Vascular Ltd. develops dual-balloon catheter technology to treat Peripheral Vascular Disease (PVD).
Sector
Subsector
Keywords
Location
Euphrates Vascular
Euphrates Vascular develops medical devices that treat vascular occlusions related to vascular disease.
Sector
Subsector
Keywords
Location
total rounds
total raised
Zorion Medical
Zorion Medical is developing a device platform that treats cardiovascular disease.
Sector
Subsector
Location
Shockwave Medical
Shockwave Medical is a medical device company that develops and manufactures balloon dilatation catheters for cardiovascular disease.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 20.02.2024. Their latest investor Blue Ridge Medical. Their latest round Series C
U.S. Venture Partners
US Venture Partners is a venture capital firm that invests in early-stage ventures in information technology and healthcare.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors7
Number of lead investors
Number of investors
Blue Ridge Medical
Blue Ridge Medical Group offers a wide range of medical services.
Sector
Subsector
Keywords
Location
count Of Investments
U.S. Venture Partners
US Venture Partners is a venture capital firm that invests in early-stage ventures in information technology and healthcare.
Sector
Subsector
Location
count Of Investments
count Of Exists
Casey Tansey
Casey Tansey joined USVP as a general partner in April 2005. A veteran of the medical device industry, Casey brings over 25 years of entrepreneurial, early-stage medical device and seasoned operating experience to USVP. Casey's extensive operations experience brings more to the table than strategic counsel -- he adds empathy to that mix. Casey's investment strategy is a lot like his strategy as a CEO: identify unmet clinical needs where patients are in need of new and improved products and services. At USVP, Casey focuses on the trend toward the miniaturization of devices and the development of minimally-invasive technologies that promise innovations in the delivery of medical products and services, especially in cardiovascular products, orthopedics, spinal care and neurology. Casey's passion is to strive for delivery of medical services with less trauma to the patient and improved quality of life. Innovations shaping this trend include minimally-invasive technologies. During his tenure as CEO and President of Epicor Medical from 2001 to 2004, Casey, along with a dedicated team, pioneered a minimally-invasive treatment for atrial fibrillation and transformed the company into a recognized market leader, and he led Epicor's acquisition by St. Jude Medical. Prior to Epicor, Casey was CEO and President of Heartport, a public company that helped pioneer minimally-invasive cardiac surgery which is now a Johnson & Johnson company. Before that, he was with Baxter Edward's Cardiovascular Division for nearly ten years, holding various sales and marketing positions. During his tenure at Baxter, Casey was involved in launching innovative heart valve products that have grown to be the market leaders. Casey serves on the Board of Directors for ApniCure, CardioKinetix, Devax, Inspire Medical, Intersect ENT, Intuity Medical, ReShape Medical, and SentreHEART. In addition, he served as the Chairman of the Board of Directors of the World Heart Foundation, an organization dedicated to advancing humanitarian efforts in heart surgery worldwide through education and collaboration. Casey holds a B.S. and M.B.A. from the College of Notre Dame in Belmont, CA. Casey has served on the boards of Epicor Medical and Heartport.
current job
Sectoral Asset Management
Sectoral Asset Management is a specialist in managing global investment portfolios in the healthcare sector.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders4
Carol A. Burns
Carol Burns is a serial entrepreneur with extensive experience working in the cardiovascular sector. She has proven success in raising capital, recruiting high performance management teams and top scientific advisors. Ms. Burns has led product development, created worldwide product awareness and has achieved regulatory milestones in a high-quality, timely and capital efficient manner. Ms. Burns recently served as co-founder, President & CEO of Intact Vascular (Wayne, PA) and raised $17M in capital to develop the Tack Endovascular System, a Nitinol implant in a multi-loaded catheter for treatment of peripheral artery disease. Prior to Intact Vascular, she was the first employee of another peripheral vascular company, Embrella Cardiovascular. Ms. Burns served as the Vice President of Product and Business Development which developed a novel embolic protection device for use in Transcatheter Aortic Valve Replacement (TAVR) procedures (acquired by Edwards Lifesciences). Ms. Burns also worked at Animas Corporation (acquired by Johnson and Johnson) as the Sr. Director of International Sales and Marketing. She served as the Managing Director, Europe at Ventrica, Inc. (acquired by Medtronic) and held various management positions at Guidant Corporation working in the cardiac and vascular surgery division where she played a key role in the launch of the first US marketed endovascular abdominal aortic aneurysm device and endoscopic vessel harvesting product for coronary artery bypass surgery. Ms. Burns received her BSN degree from The College of New Jersey, in Ewing, New Jersey.
current job
organization founded
Carol A. Burns
Robert M. Giasolli
current job
organization founded
Robert M. Giasolli
Peter Schneider
Peter Schneider is a Board Certified Vascular Surgeon who currently practices at Kaiser Permanente Clinic in Honolulu, Hawaii. He is a graduate of Johns Hopkins University School of Medicine. Dr. Schneider is an early adopter of endovascular techniques and has authored multiple scientific publications and books including Endovascular Skills (third edition textbook on endovascular techniques used by fellows and practitioners), Critical Limb Ischemia and Carotid Interventions. Dr. Schneider is also a frequent invited guest lecturer at national and international conferences. He is the Co-Principal Investigator (PI) of Medtronic’s IN.Pact US drug coated balloon trial. He also served as the PI in a carotid stent trial sponsored by WL Gore. Dr. Schneider is an advisor to several start-up companies including Revascular, Silk Road and Pro-med and serves on the scientific advisory boards of Abbott Vascular, Cardinal Health and Medtronic. In addition to his clinical and academic experience Dr. Schneider is also an inventor. He has licensed vascular devices to Cook Medical (tibial sheath) and developed a marker catheter for carotid interventions which was licensed to Angiodynamics. Dr. Schneider is a co-founder, of Cagent Vascular and was also a co-founder for Intact Vascular.
current job
organization founded
Peter Schneider
Employee Profiles5
Lauren Pfeiffer
Marketing and communications manager
Robert M. Giasolli
Founder, CTO, and VP of Research and Development
Activity
Recent News2
The graph reveals the ratio (%) of positive news articles in a chosen time range